Dec. 29, 2020

Union Health Minister Harsh Vardhan inaugurated India's first pneumococcal conjugate vaccine "Pneumosil".


  • It has been developed by the Serum Institute of India Private Limited (SIIPL) in collaboration with partners like the Bill and Melinda Gates Foundation.

  • SIIPL developed and got the license of the first indigenous Pneumococcal Conjugate Vaccine (PCV) from the Government of India during COVID-19 pandemic lock-down.

  • This Indigenous Pneumococcal Conjugate Vaccine will be available in the market under the brand name "Pneumosil" at an affordable price in a single dose (vial and pre-filled syringe) and Multidose (vial) presentations.

  • Pneumosil is effective in the prevention of Pneumonia disease.